Henry Schein Acquires Majority Interest in TriMed, Inc.

April 4, 2024

Henry Schein, Inc. completed the acquisition of a majority interest in TriMed, Inc., a Santa Clarita, California–based developer of orthopedic implants and solutions for lower and upper extremities. TriMed reported approximately $52 million in 2023 net sales; the TriMed founders will remain with the business and financial terms were not disclosed. Henry Schein said the deal will broaden its surgical product offering to IDNs and ASCs and is expected to be neutral to 2024 non-GAAP EPS and accretive thereafter.

Buyers
Henry Schein, Inc.
Targets
TriMed, Inc.
Industry
Medical Devices
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.